No document available.
Keywords :
Adaptor Proteins, Signal Transducing; Peptides; Promoter Regions (Genetics); Proteins; Rats; Receptors, Cytokine; Receptors, Oncostatin M; Signal Transduction; Tyrosine; Oncostatin M; Mitogen-Activated Protein Kinases; Lymphokines; Adaptor Proteins, Vesicular Transport; Animals; COS Cells; Dimerization; GRB2 Adaptor Protein; Growth Inhibitors; Interleukin-6; Leukemia Inhibitory Factor; alpha-Macroglobulins
Abstract :
[en] The common use of the cytokine receptor gp130 has served as an explanation for the extremely redundant biological activities exerted by interleukin (IL)-6-type cytokines. Indeed, hardly any differences in signal transduction initiated by these cytokines are known. In the present study, we demonstrate that oncostatin M (OSM), but not IL-6 or leukemia inhibitory factor, induces tyrosine phosphorylation of the Shc isoforms p52 and p66 and their association with Grb2. Concomitantly, OSM turns out to be a stronger activator of ERK1/2 MAPKs. Shc is recruited to the OSM receptor (OSMR), but not to gp130. Binding involves Tyr(861) of the OSMR, located within a consensus binding sequence for the Shc PTB domain. Moreover, Tyr(861) is essential for activation of ERK1/2 and for full activation of the alpha(2)-macroglobulin promoter, but not for an exclusively STAT-responsive promoter. This study therefore provides evidence for qualitative differential signaling mechanisms exerted by IL-6-type cytokines.
Scopus citations®
without self-citations
52